BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 36380871)

  • 1. FOXK2 transcription factor and its roles in tumorigenesis (Review).
    Wang Z; Liu X; Wang Z; Hu Z
    Oncol Lett; 2022 Dec; 24(6):461. PubMed ID: 36380871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXK2 Transcription Factor and Its Emerging Roles in Cancer.
    Nestal de Moraes G; Carneiro LDT; Maia RC; Lam EW; Sharrocks AD
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30897782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXK2 regulates PFKFB3 in promoting glycolysis and tumorigenesis in multiple myeloma.
    Liu X; Tang N; Liu Y; Fu J; Zhao Y; Wang H; Wang H; Hu Z
    Leuk Res; 2023 Sep; 132():107343. PubMed ID: 37356282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and roles of FOXK2 in cancer.
    Kang Y; Zhang K; Sun L; Zhang Y
    Front Oncol; 2022; 12():967625. PubMed ID: 36172141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 6. FOXK2 suppresses the malignant phenotype and induces apoptosis through inhibition of EGFR in clear-cell renal cell carcinoma.
    Zhang F; Ma X; Li H; Zhang Y; Li X; Chen L; Guo G; Gao Y; Gu L; Xie Y; Duan J; Zhang X
    Int J Cancer; 2018 Jun; 142(12):2543-2557. PubMed ID: 29368368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis.
    Wang B; Zhang X; Wang W; Zhu Z; Tang F; Wang D; Liu X; Zhuang H; Yan X
    Onco Targets Ther; 2018; 11():1067-1075. PubMed ID: 29520156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
    Liu Y; Ao X; Jia Z; Bai XY; Xu Z; Hu G; Jiang X; Chen M; Wu H
    Sci Rep; 2015 Mar; 5():8796. PubMed ID: 25740706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The deacetylation of Foxk2 by Sirt1 reduces chemosensitivity to cisplatin.
    Wang XW; Guo QQ; Yu Y; Zhou TT; Zhang SY; Wang Z; Liu JW; Tang J; Jiang XY; Wang SS; Guo WD; Xu HD; Sun HY; Li ZW; Song XY; Zhao JG; Cao L
    J Cell Mol Med; 2022 Jan; 26(2):491-506. PubMed ID: 34866322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of FOXK2 is associated with poor prognosis in patients with gastric cancer.
    Liu X; Wei X; Niu W; Wang D; Wang B; Zhuang H
    Mol Med Rep; 2018 Nov; 18(5):4356-4364. PubMed ID: 30221666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sox9 mediated transcriptional activation of FOXK2 is critical for colorectal cancer cells proliferation.
    Qian Y; Xia S; Feng Z
    Biochem Biophys Res Commun; 2017 Jan; 483(1):475-481. PubMed ID: 28007600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Forkhead box K2 modulates epirubicin and paclitaxel sensitivity through FOXO3a in breast cancer.
    Nestal de Moraes G; Khongkow P; Gong C; Yao S; Gomes AR; Ji Z; Kandola N; Delbue D; Man EP; Khoo US; Sharrocks AD; Lam EW
    Oncogenesis; 2015 Sep; 4(9):e167. PubMed ID: 26344694
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Yu Y; Cao WM; Cheng F; Shi Z; Han L; Yi JL; da Silva EM; Dopeso H; Chen H; Yang J; Wang X; Zhang C; Zhang H
    bioRxiv; 2023 May; ():. PubMed ID: 37398114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXK2 downregulation suppresses EMT in hepatocellular carcinoma.
    Kong J; Zhang Q; Liang X; Sun W
    Open Med (Wars); 2020; 15(1):702-708. PubMed ID: 33313412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells.
    Nestal de Moraes G; Ji Z; Fan LY; Yao S; Zona S; Sharrocks AD; Lam EW
    Oncogenesis; 2018 Mar; 7(3):29. PubMed ID: 29540677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway.
    Zhang Y; Wang Y; Zhao G; Tanner EJ; Adli M; Matei D
    J Clin Invest; 2022 May; 132(10):. PubMed ID: 35349489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The forkhead transcription factor FOXK2 premarks lineage-specific genes in human embryonic stem cells for activation during differentiation.
    Ji Z; Li Y; Liu SX; Sharrocks AD
    Nucleic Acids Res; 2021 Feb; 49(3):1345-1363. PubMed ID: 33434264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
    Okino Y; Machida Y; Frankland-Searby S; Machida YJ
    J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxk2 inhibits non-small cell lung cancer epithelial-mesenchymal transition and proliferation through the repression of different key target genes.
    Chen S; Jiang S; Hu F; Xu Y; Wang T; Mei Q
    Oncol Rep; 2017 Apr; 37(4):2335-2347. PubMed ID: 28260088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The forkhead transcription factor FOXK2 promotes AP-1-mediated transcriptional regulation.
    Ji Z; Donaldson IJ; Liu J; Hayes A; Zeef LA; Sharrocks AD
    Mol Cell Biol; 2012 Jan; 32(2):385-98. PubMed ID: 22083952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.